Dual Immunotherapy and Liver Perfusion Delays Progression in Uveal Melanoma
(MedPage Today) -- Adding the dual checkpoint inhibitor regimen of ipilimumab (Yervoy) and nivolumab (Opdivo) to percutaneous hepatic perfusion significantly ...
Tag: Uveal
(MedPage Today) -- Adding the dual checkpoint inhibitor regimen of ipilimumab (Yervoy) and nivolumab (Opdivo) to percutaneous hepatic perfusion significantly ...